Market closed
Nevro/$NVRO
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Nevro
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
Ticker
$NVRO
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,215
Website
Nevro Metrics
BasicAdvanced
$167M
Market cap
-
P/E ratio
-$1.89
EPS
0.93
Beta
-
Dividend rate
Price and volume
Market cap
$167M
Beta
0.93
52-week high
$22.64
52-week low
$4.38
Average daily volume
499K
Financial strength
Current ratio
5.023
Quick ratio
3.644
Long term debt to equity
76.262
Total debt to equity
90.239
Interest coverage (TTM)
-4.13%
Management effectiveness
Return on assets (TTM)
-9.02%
Return on equity (TTM)
-24.78%
Valuation
Price to revenue (TTM)
0.39
Price to book
0.61
Price to tangible book (TTM)
0.79
Price to free cash flow (TTM)
-2.889
Growth
Revenue change (TTM)
-0.87%
Earnings per share change (TTM)
-34.33%
3-year revenue growth (CAGR)
2.09%
3-year earnings per share growth (CAGR)
-15.47%
What the Analysts think about Nevro
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Nevro stock.
Nevro Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Nevro Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Nevro News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Nevro stock?
Nevro (NVRO) has a market cap of $167M as of November 15, 2024.
What is the P/E ratio for Nevro stock?
The price to earnings (P/E) ratio for Nevro (NVRO) stock is 0 as of November 15, 2024.
Does Nevro stock pay dividends?
No, Nevro (NVRO) stock does not pay dividends to its shareholders as of November 15, 2024.
When is the next Nevro dividend payment date?
Nevro (NVRO) stock does not pay dividends to its shareholders.
What is the beta indicator for Nevro?
Nevro (NVRO) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.